Price
Target price
?
?
2.020%
0.8
2.020%
€61.81
08:48 / Frankfurt
WKN: A0DN17 / Symbol: PBH / Name: Prestige Consumer Healthcare / Stock / Food & Drug Retailing / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. gained 2.020% today.
Our community is currently high on Prestige Consumer Healthcare Inc. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 61 € shows a very positive potential of 50.99% compared to the current price of 40.4 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 2.020% | -2.941% | -15.745% | -46.122% | -25.981% | -25.283% | -3.883% |
| Apollo Medical Holdings, Inc. | -0.610% | 1.863% | 9.333% | 51.852% | 54.717% | 5.806% | - |
| Petmed Express Inc | 0.550% | -21.228% | -25.824% | -57.672% | -49.342% | -89.783% | -94.555% |
| Suzuken Co Ltd | 1.500% | -5.000% | -9.524% | 6.400% | -18.902% | 6.400% | 6.400% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat